ACCO Brands Corporation
NYSE:ACCOBusiness Equipment & Supplies
+$0.05 today
- Market cap
- $517.11M
- Beta
- 1.21
- P/E (TTM)
- 4.9
- EPS (TTM)
- $0.80
- Dividend yield
- 7.70%
Volume 1.77M
Average 1.07M
ACCO Net Income
Bottom-line profit after all expenses, interest, and taxes.
ACCO Brands CorporationNYSE: ACCO
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns positive
Q1 FY2026 net income was $19.4M, compared with -$13.2M a year earlier. Trailing-twelve-month net income was $73.9M.
Context
- Net income amounted to 2.7% of revenue in FY2025, down 3.4 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of $88.81M (+115.0%) for the fiscal year ending Dec 2026, a slowdown from the +140.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $19.4M-8.9% QoQ
- Last fiscal yearDec 2025
- $41.3M+140.6% YoY
- LTMMar 2026
- $73.9M+168.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +247.0% | -12.3% | -259.3 pp |
| 1 year | +140.6% | +115.0% | -25.6 pp |
| 3-year CAGR | — | +31.5% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- 41.3M USD
- Year-over-year change
- +140.6%
- 4-year CAGR
- -20.2%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 41.3M | +140.6% |
| FY2024 | 2024-12-31 | (101.6M) | -366.1% |
| FY2023 | 2023-12-31 | (21.8M) | -65.2% |
| FY2022 | 2022-12-31 | (13.2M) | -113.0% |
| FY2021 | 2021-12-31 | 101.9M | — |
Net Income vs competitors
How ACCO compares with its peers on the latest reported figures
- ACCO's LTM Mar 2026 net income of $73.9M is the highest of the 11 companies compared; the peer median is $14.73M.
- Its year-over-year change of +168.1% is the highest of 11, against a peer median of -18.8%.
- Net income amounts to 4.8% of revenue for ACCO, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $73.9M | +168.1% | — | 4.8% | |
| LTM Mar 2026 | $48.55M | +149.6% | — | 76.4% | |
| LTM Feb 2026 | $42.63M | +6.0% | -3.4% | 10.9% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $40.79M | -17.4% | +100.6% | 24.1% |
| LTM Mar 2026 | $24.5M | -20.2% | — | 1.5% | |
| LTM Mar 2026 | $18.31M | +28.8% | -26.5% | 4.9% | |
| LTM Mar 2026 | $11.16M | -69.4% | — | 2.0% | |
| LTM Apr 2026 | $9.12M | -36.4% | -39.4% | 2.2% | |
| LTM Mar 2026 | $7.5M | -83.3% | — | 0.3% | |
| LTM Mar 2026 | $5.8M | -72.6% | -34.1% | 1.6% | |
| LTM Mar 2026 | -$64.61M | +9.4% | +23.5% | 4.4% | |
| Peer median (excluding ACCO) | $14.73M | -18.8% | -15.0% | 3.3% | |
Competitors are the stored peer set for ACCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.03B | 1.95B | 1.83B | 1.67B | 1.52B |
| Cost of Revenue | 1.41B | 1.4B | 1.23B | 1.11B | 1.07B |
| Gross Profit | 614.9M | 552.3M | 598.3M | 555.4M | 454.9M |
| Gross Margin | 30.4% | 28.4% | 32.6% | 33.3% | 29.8% |
| Research & Development | 26.6M | 26.3M | 25.8M | 23M | 22M |
| Selling, General & Admin | 392.6M | 376.7M | 395.3M | 371.8M | 324.7M |
| Operating Expenses | 463.9M | 517.5M | 553.6M | 592.4M | 346.7M |
| Depreciation & Amortization | 85.7M | 79.4M | 76.1M | 73.1M | 72.8M |
| EBITDA | 243.4M | 139.9M | 121.6M | 38.4M | 167.7M |
| EBITDA Margin | 12.0% | 7.2% | 6.6% | 2.3% | 11.0% |
| Operating Income | 151M | 34.8M | 44.7M | (37M) | 108.2M |
| Operating Margin | 7.5% | 1.8% | 2.4% | -2.2% | 7.1% |
| Interest Income | 1.9M | 8.3M | 7.1M | 7.5M | 9.4M |
| Interest Expense | 46.3M | 45.6M | 58.6M | 52.6M | 45.8M |
| Other Income / Expenses | (39.6M) | (19.9M) | (57.8M) | (50.3M) | (59.1M) |
| Income Before Tax | 111.4M | 14.9M | (13.1M) | (87.3M) | 49.1M |
| Pre-Tax Margin | 5.5% | 0.8% | -0.7% | -5.2% | 3.2% |
| Income Tax Expense | 9.5M | 28.1M | 8.7M | 14.3M | 7.8M |
| Net Income | 101.9M | (13.2M) | (21.8M) | (101.6M) | 41.3M |
| Net Margin | 5.0% | -0.7% | -1.2% | -6.1% | 2.7% |
| EPS (Basic) | 1.07 | (0.14) | (0.23) | (1.06) | 0.45 |
| EPS (Diluted) | 1.05 | (0.14) | (0.23) | (1.06) | 0.44 |
| Weighted Avg Shares | 95.5M | 95.3M | 95.3M | 95.6M | 92.1M |
| Weighted Avg Shares (Diluted) | 97.1M | 95.3M | 95.3M | 95.6M | 94M |
ACCO Brands Corporation
NYSE:ACCO
Intrinsic Alpha fair value
Locked
Current Price
$5.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.